Discover the latest insights from the TOReTO study on COPD management: Dual bronchodilator therapy has been shown to reduce exacerbations, with varying efficacy between current and former smokers.
Conclusion: Tiotropium appears to be at least as effective as currently available alternatives in the treatment of patients with COPD who require daily bronchodilator treatment. Its simplified ...
Background: In contrast to asthma, the indication for bronchodilators prior to bronchoscopy in patients with COPD has not been ... did not receive any inhaled medication. Spirometry was performed ...
This includes steroid-containing combinations and long-acting bronchodilators ... should be the foundation treatment for the majority of symptomatic COPD patients. In the CRYSTAL study, patients ...
Current treatment options for COPD include bronchodilators such as beta2-agonists and anticholinergics, standalone or combination inhaled corticosteroids (ICS), and other combination medications.
This broad utilization across all patient types is consistent with market research and supports our belief that Ohtuvayre’s bronchodilator ... for COPD patients and can re-define the treatment ...
Traditionally, COPD management has relied on bronchodilators ... now you have an entirely new category of treatment options that are minimally invasive. There is one that's currently available ...
Ohtuvayre™ (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti ...